BRCA2 and ovarian cancer: Carriers of germline mutations in BRCA1 and BRCA2 genes have a lifetime risk of ovarian cancer of 35–60% and 12–25%, respectively, along with an increased risk of peritoneal and fallopian tube malignancies [24,25,26].